Women's Health Issues
Volume 19, Issue 1 , Pages 70-78 , January 2009

Financial and Quality-of-Life Burden of Dysfunctional Uterine Bleeding Among Women Agreeing To Obtain Surgical Treatment

  • Kevin D. Frick, PhD

      Affiliations

    • Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
    • Corresponding Author InformationCorrespondence to: Kevin D. Frick, PhD, Johns Hopkins Bloomberg School of Public Health, 624 N. Broadway, Rm. 606, Baltimore MD 21205. Phone: 410-614-4018; Fax: 410-955-0470.
    • ,
  • Melissa A. Clark, PhD

      Affiliations

    • Brown University, School of Medicine, Providence, Rhode Island
    • ,
  • Donald M. Steinwachs, PhD

      Affiliations

    • Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
    • ,
  • Patricia Langenberg, PhD

      Affiliations

    • School of Medicine, University of Maryland, Baltimore, Maryland
    • ,
  • Dale Stovall, MD

      Affiliations

    • University of Virginia, Richmond, Virginia
    • ,
  • Malcolm G. Munro, MD

      Affiliations

    • David Geffen School of Medicine at UCLA, Los Angles, California
    • ,
  • Kay Dickersin, PhD

      Affiliations

    • Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
    • ,
  • The STOP-DUB Research Group

Received 6 March 2008 ,Revised 27 June 2008 ,Accepted 16 July 2008.

References 

  1. Blau FD. Trends in the well-being of American women, 1970–1995. Journal of Economic Literature. 1998;36:112–165
  2. Blumenthal PD, Trussell J, Singh RH, Guo A, Borenstein J, Dubois RW, et al. Cost-effectiveness of treatments for dysfunctional uterine bleeding in women who need contraception. Contraception. 2006;74:249–258
  3. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. Journal of Health Economics. 2002;21:271–292
  4. Brazier J, Usherwood T, Harper R, Thomas K. Deriving a preference-based single index from the UK SF-36 health survey. Journal of Clinical Epidemiology. 1998;51:1115–1128
  5. Briggs A. Probabilistic analysis of cost-effectiveness models: Statistical representation of parameter uncertainty. Value in Health. 2005;8:1–2
  6. Cote I, Jacobs P, Cumming D. Work loss associated with increased menstrual loss in the united states. Obstetrics and Gynecology. 2002;100:683–687
  7. Dickersin K, Munro M, Langenberg P, Scherer R, Frick KD, Weber AM, et al. Surgical treatments outcomes project for dysfunctional uterine bleeding (STOP-DUB): Design and methods. Controlled Clinical Trials. 2003;24:591–609
  8. Dickersin K, Munro MG, Clark M, Langenberg P, Scherer R, Frick K, et al. Surgical Treatments Outcomes Project for Dysfunctional Uterine Bleeding (STOP-DUB) Research Group Hysterectomy compared with endometrial ablation for dysfunctional uterine bleeding: a randomized controlled trial. Obstetrics and Gynecology. 2007;110:1279–1289
  9. Dolan P. Modeling valuations for EuroQol health states. Medical Care. 1997;35:1095–1108
  10. Duleba AJ, Heppard MC, Soderstrom RM, Townsend DE. A randomized study comparing endometrial cryoablation and rollerball electroablation for treatment of dysfunctional uterine bleeding. Journal of the American Association of Gynecologic Laparoscopists. 2003;10:17–26
  11. Espallargues M, Czoski-Murray CJ, Bansback NJ, Carlton J, Lewis GM, Hughes LA, et al. The impact of age-related macular degeneration on health status utility values. Investigative Ophthalmology & Visual Science. 2005;46:4016–4023
  12. Geller SE, Harlow SD, Bernstein SJ. Differences in menstrual bleeding characteristics, functional status, and attitudes toward menstruation in three groups of women. Journal of Women's Health & Gender Based Medicine. 1999;8:533–540
  13. Gold EB, Bromberger J, Crawford S, Samuels S, Greendale GA, Harlow SD, et al. Factors associated with age at natural menopause in a multiethnic sample of midlife women. American Journal of Epidemiology. 2001;153:865–874
  14. In:  Gold MR,  Siegel JE,  Russell LB,  Weinstein MC editor. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996;
  15. Hawe J, Abbott J, Hunter D, Phillips G, Garry R. A randomised controlled trial comparing the cavaterm endometrial ablation system with the nd:YAG laser for the treatment of dysfunctional uterine bleeding. British Journal of Obstetrics and Gynecology. 2003;110:350–357
  16. Higham JM, Shaw RW. Clinical associations with objective menstrual blood volume. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 1999;82:73–76
  17. Hurskainen R, Aalto AM, Teperi J, Grenman S, Kivela A, Kujansuu E, et al. Psychosocial and other characteristics of women complaining of menorrhagia, with and without actual increased menstrual blood loss. British Journal of Obstetrics and Gynecology. 2001;108:281–285
  18. Kato I, Toniolo P, Akhmedkhanov A, Koenig KL, Shore R, Zeleniuch-Jacquotte A. Prospective study of factors influencing the onset of natural menopause. Journal of Clinical Epidemiology. 1998;51:1271–1276
  19. Kucuk M, Okman TK. Intrauterine instillation of trichloroacetic acid is effective for the treatment of dysfunctional uterine bleeding. Fertility and Sterility. 2005;83:189–194
  20. Lethaby A, Shepperd S, Cooke I, Farquhar C. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. The Cochrane Database of Systematic Reviews. 1999;Issue 2. Art. No.: CD000329
  21. Liu Z, Doan QV, Blumenthal P, Dubois RW. A systematic review evaluating health-related quality of life, work impairment, and health-care costs and utilization in abnormal uterine bleeding. Value in Health. 2007;10:183–194
  22. Livingstone M, Fraser IS. Mechanisms of abnormal uterine bleeding. Human Reproduction Update. 2002;8:60–67
  23. Lofland JH, Pizzi L, Frick KD. A review of health-related workplace productivity loss instruments. Pharmacoeconomics. 2004;22:165–184
  24. Marjoribanks J, Lethaby A, Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database of Systematic Reviews. 2006;2:CD003855
  25. McPherson K, Herbert A, Judge A, Clarke A, Bridgman S, Maresh M, et al. Psychosexual health 5 years after hysterectomy: Population-based comparison with endometrial ablation for dysfunctional uterine bleeding. Health Expectations. 2005;8:234–243
  26. Nichols CM, Gill EJ. Thermal balloon endometrial ablation for management of acute uterine hemorrhage. Obstetrics and Gynecology. 2002;100:1092–1094
  27. Reynolds RF, Obermeyer CM. Age at natural menopause in Spain and the United States: Results from the DAMES project. American Journal of Human Biology. 2005;17:331–340
  28. Rosenfeld JA. Treatment decisions in the management of menorrhagia. Medscape Women's Health. 1997;2:6
  29. Ruta DA, Garratt AM, Chadha YC, Flett GM, Hall MH, Russell IT. Assessment of patients with menorrhagia: How valid is a structured clinical history as a measure of health status?. Quality of Life Research. 1995;4:33–40
  30. Schweikert B, Hahmann H, Leidl R. Validation of the EuroQol questionnaire in cardiac rehabilitation. Heart. 2006;92:62–67
  31. Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: Development and testing of the D1 valuation model. Medical Care. 2005;43:203–220
  32. Ubel PA, Hirth RA, Chernew ME, Fendrick AM. What is the price of life and why doesn't it increase at the rate of inflation?. Archives of Internal Medicine. 2003;163:1637–1641
  33. Varner RE, Ireland CC, Summitt RL, Richter HE, Learman LA, Vittinghoff E, et al. Medicine or surgery (ms): A randomized clinical trial comparing hysterectomy and medical treatment in premenopausal women with abnormal uterine bleeding. Controlled Clinical Trials. 2004;25:104–118
  34. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. conceptual framework and item selection. Medical Care. 1992;30:473–483
  35. Wildi SM, Cox MH, Clark LL, Turner R, Hawes RH, Hoffman BJ, et al. Assessment of health state utilities and quality of life in patients with malignant esophageal dysphagia. American Journal of Gastroenterology. 2004;99:1044–1049

 Funded by Grant #5U01 HS09506 from the Agency for Healthcare Research and Quality to the University of Maryland (1996 to 1998) and Brown Medical School (1998–2001), and grant #5U01 HS09506 and #5HS09506a to Brown University (2001–2005).

 Clinicaltrials.gov identifier: NCT00114088.

PII: S1049-3867(08)00098-4

doi: 10.1016/j.whi.2008.07.002

Women's Health Issues
Volume 19, Issue 1 , Pages 70-78 , January 2009

Article Tools